Equitable Holdings
EQH
$41.59
+2.62%
Equitable Holdings is a diversified financial services company operating primarily in the insurance and asset management sectors, with core business lines in retirement solutions, asset management through its subsidiary AB, and wealth management. The company is a significant player in the annuity and retirement savings market, with its Retirement segment historically generating the majority of its revenue. The current investor narrative is heavily influenced by the company's capital return strategy, as evidenced by recent substantial share repurchase announcements, which signal management confidence but are juxtaposed against a backdrop of volatile quarterly earnings and a challenging revenue environment.…
EQH
Equitable Holdings
$41.59
Related headlines
Investment Opinion: Should I buy EQH Today?
Rating: Hold. The core thesis is that while EQH is deeply undervalued and has bullish analyst support, the extreme fundamental risks—particularly its negative equity and erratic earnings—are too severe to justify a Buy rating, making it suitable only for highly risk-tolerant investors seeking a speculative turnaround.
Supporting evidence for this cautious view includes a modest valuation with a PS ratio of 1.22 and EV/Sales of 0.88, which is cheap historically. Analyst sentiment is unanimously bullish among major firms, suggesting professional conviction. The company generated positive FCF of $737M TTM, funding its share buybacks. However, these are overshadowed by a TTM net loss, a -9.5% YoY revenue decline in Q4, and the alarming negative debt-to-equity ratio.
The thesis would upgrade to a speculative Buy if the company reports two consecutive quarters of sustained profitability (net income > $0) and shows stabilization in shareholder equity. It would downgrade to a Sell if revenue decline accelerates beyond -10% YoY or if the negative equity position worsens significantly. Based on the current data, the stock is fairly valued relative to its substantial risks—it is not overvalued given its depressed price, but the valuation discount is fully warranted by its operational and financial challenges.
Sign up to view all
EQH 12-Month Price Forecast
The outlook for EQH is bifurcated and hinges on the sustainability of its Q4 2025 profitability. The neutral stance reflects this high uncertainty: the stock is too risky for a bullish call given its broken balance sheet, yet too cheap and supported by analyst sentiment for a bearish call. The base case of range-bound volatility is most probable, as the company likely continues to struggle for traction. Confidence is medium because the next two quarterly reports will be critical in validating or invalidating the turnaround narrative. The stance would upgrade to bullish only upon clear evidence of two consecutive profitable quarters and balance sheet repair. It would downgrade to bearish if losses re-emerge, confirming the company is in a structural decline.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Equitable Holdings's 12-month outlook, with a consensus price target around $54.07 and implied upside of +30.0% versus the current price.
Average Target
$54.07
2 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
2
covering this stock
Price Range
$33 - $54
Analyst target range
Analyst coverage appears limited with only 2 analysts providing estimates, indicating this may be a less-followed name among institutional investors, which can contribute to higher volatility and less efficient price discovery. The consensus sentiment from recent institutional ratings is bullish, with firms like Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays all maintaining 'Overweight' or 'Buy' ratings throughout early 2026, suggesting professional analysts see value at current depressed levels. The target price range implied by EPS estimates is wide, with a low of $11.22 and a high of $13.16 based on their EPS forecasts, but a formal consensus target price and implied upside are not provided in the dataset, preventing a precise calculation of market expectations versus the current price of $41.35.
Bulls vs Bears: EQH Investment Factors
The investment debate for EQH is a stark clash between deep-value opportunity and fundamental distress. The bear side currently holds stronger evidence, anchored by catastrophic quarterly losses, a distressed balance sheet with negative equity, and persistent revenue declines. These are not minor issues but existential red flags. The bull case rests on the premise that such extreme negativity is already reflected in a valuation near historical lows, and that management's capital returns and a potential Q4 turnaround can spark a recovery. The single most important tension is whether the Q4 2025 profit rebound represents a sustainable operational inflection or merely a temporary respite within a continuing downward spiral. The resolution of this question will determine if the stock is a compelling value play or a value trap.
Bullish
- Deeply Undervalued on Sales Basis: The stock trades at a trailing Price-to-Sales (PS) ratio of 1.22 and an EV-to-Sales of 0.88, which is near the bottom of its multi-year historical range (down from a high of 12.28). This suggests significant pessimism is priced in, offering a potential value opportunity if fundamentals stabilize.
- Strong Analyst Conviction: Despite limited coverage, major institutions like Morgan Stanley, Wells Fargo, UBS, JP Morgan, and Barclays maintain 'Overweight' or 'Buy' ratings. This consensus bullish sentiment from professional analysts indicates they see value at current depressed price levels.
- Robust Capital Return via Buybacks: Recent news highlights substantial share repurchase announcements, signaling management confidence. This capital return strategy provides a tailwind to EPS and shareholder value, supported by positive trailing twelve-month free cash flow of $737 million.
- Oversold Technical Condition: The stock is down 22.7% over the past year and trades at $41.35, only 16% above its 52-week low of $35.20. This deeply oversold condition, coupled with a -50.9% 1-year relative strength, suggests the potential for a technical rebound if negative sentiment abates.
Bearish
- Extreme Earnings Volatility & Losses: Trailing twelve-month EPS is negative at -$0.097, driven by a catastrophic Q3 2025 net loss of -$1.31 billion. This erratic profitability, with gross margins swinging from -17% to 88%, indicates severe underlying operational instability.
- Severe Balance Sheet Distress: The company reports a negative debt-to-equity ratio of -88.68, an artifact of negative shareholder equity, raising fundamental solvency concerns. A current ratio of 0.57 also signals potential short-term liquidity constraints.
- Persistent Revenue Decline: Q4 2025 revenue of $3.28 billion declined 9.5% year-over-year from $3.62 billion. The multi-quarter trend is inconsistent and negative, pointing to challenges in its primary revenue-generating Retirement segment.
- Chronic Underperformance vs. Market: The stock has a 1-year relative strength of -50.9% and has underperformed the S&P 500 by over 50 percentage points. This persistent weakness, despite analyst bullishness, suggests the market is discounting the company's prospects due to fundamental flaws.
EQH Technical Analysis
The stock is in a pronounced downtrend, with a 1-year price change of -22.72% and a 6-month decline of -11.44%, significantly underperforming the broader market. Currently trading at $41.35, it sits near the lower end of its 52-week range of $35.20 to $56.61, positioning it at approximately 16% of that range, which suggests the stock is deeply oversold and may present a value opportunity, though it risks being a 'falling knife' if fundamental pressures persist. Recent momentum shows a slight 3-month gain of 2.81%, but this is overshadowed by a 1-month loss of -0.29% and a stark negative relative strength of -50.93% over the past year, indicating any short-term bounce lacks conviction and remains within a broader bearish context. Key technical support is the 52-week low of $35.20, while resistance is at the 52-week high of $56.61; a sustained breakdown below support could trigger further selling, whereas a recovery above $45 would be needed to signal a potential trend reversal. The stock's beta of 1.13 indicates it is 13% more volatile than the market, which is a relevant consideration for risk-adjusted positioning given its recent drawdown of -37.01%.
Beta
1.13
1.13x market volatility
Max Drawdown
-37.0%
Largest decline past year
52-Week Range
$35-$57
Price range past year
Annual Return
-21.1%
Cumulative gain past year
| Period | EQH Return | S&P 500 |
|---|---|---|
| 1m | -1.4% | +5.4% |
| 3m | +3.6% | +10.9% |
| 6m | -9.5% | +11.0% |
| 1y | -21.1% | +28.1% |
| ytd | -13.3% | +11.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
EQH Fundamental Analysis
Revenue trajectory is volatile and recently negative, with Q4 2025 revenue of $3.28 billion representing a year-over-year decline of -9.5% from the prior-year quarter's $3.62 billion. The multi-quarter trend is inconsistent, swinging from a strong Q4 2024 to significant losses in Q2 and Q3 2025, indicating underlying operational challenges, particularly in its core Retirement segment which drives most revenue. Profitability is highly erratic, with Q4 2025 net income of $215 million and a gross margin of 88.07%, but this follows a disastrous Q3 2025 net loss of -$1.31 billion and a gross margin of -16.97%; the trailing twelve-month EPS is negative at -$0.097, highlighting that recent quarterly profits have not fully offset earlier severe losses. The balance sheet shows a negative debt-to-equity ratio of -88.68, which is an unusual artifact likely due to negative shareholder equity, raising significant financial health concerns; however, the company generated positive free cash flow over the trailing twelve months of $737 million, providing some internal funding capability, though the current ratio of 0.57 indicates potential short-term liquidity constraints.
Quarterly Revenue
$3.3B
2025-12
Revenue YoY Growth
-0.09%
YoY Comparison
Gross Margin
+0.88%
Latest Quarter
Free Cash Flow
$737000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is EQH Overvalued?
Given the trailing twelve-month Net Income is negative at -$0.097 per share, the primary valuation metric selected is the Price-to-Sales (PS) ratio. The trailing PS ratio is 1.22, while the forward-looking metric, EV-to-Sales, is 0.88, suggesting the market expects some revenue stabilization or efficiency improvements ahead. Compared to typical financial services and insurance peers, a PS ratio around 1.2 appears modest, potentially reflecting a discount due to the company's earnings volatility and balance sheet concerns, though direct industry average data is not available in the provided set for a quantified spread. Historically, the stock's own PS ratio has fluctuated wildly, from a high of 12.28 in Q1 2021 down to the current 1.22; trading near the bottom of its multi-year historical range suggests the market has priced in significant pessimism, which could indicate a value opportunity if the company's fundamentals stabilize, but also carries the risk of value trap if the operational deterioration continues.
PE
-10.3x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range -25x~64x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-8.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks are severe and center on earnings instability and balance sheet distress. The company's profitability is wildly volatile, as evidenced by a TTM net loss and a Q3 2025 gross margin of -16.97%. This makes forecasting nearly impossible. The balance sheet shows a negative debt-to-equity ratio of -88.68, indicating negative shareholder equity—a major red flag for financial health. While positive FCF of $737M provides some cushion, the low current ratio of 0.57 suggests potential liquidity strain in meeting short-term obligations, and revenue concentration in the volatile Retirement segment adds to earnings risk.
Market & Competitive Risks are elevated due to valuation compression and persistent underperformance. Trading at a PS ratio of 1.22, the stock may appear cheap, but this could compress further if the sector de-rates or if the company fails to stabilize. Its chronic underperformance (a -50.9% 1-year relative strength) indicates the market has lost confidence, making it difficult to attract sustained buying interest. A beta of 1.13 means it is 13% more volatile than the market, amplifying downside during broader sell-offs. Competitive pressures in the annuity and asset management space could further pressure fees and margins.
The Worst-Case Scenario involves a continuation of the operational deterioration seen in Q3 2025. If the Q4 rebound proves fleeting and the company posts another major loss, it could trigger a liquidity crisis given the weak balance sheet, leading to a credit downgrade and a forced capital raise on unfavorable terms. This could send the stock re-testing and breaking below its 52-week low of $35.20. A realistic downside from the current $41.35 would be a decline of approximately -15% to that low, but in a full-blown crisis, the stock could fall further, potentially matching the -37% maximum drawdown already experienced, implying a loss of over -35% from current levels.
FAQ
The key risks, in order of severity, are: 1) Financial Solvency Risk: The negative debt-to-equity ratio (-88.68) indicates negative shareholder equity, a major red flag. 2) Earnings Volatility Risk: The company has posted catastrophic quarterly losses (e.g., -$1.31B in Q3 2025), making profits unpredictable. 3) Operational Risk: Revenue is declining (-9.5% YoY in Q4) in its core Retirement segment. 4) Market Risk: The stock has severely underperformed the market (-50.9% 1-year relative strength) and remains highly volatile (beta of 1.13).
The 12-month forecast is highly uncertain, with three distinct scenarios. The base case (50% probability) sees the stock trading sideways between $41 and $48, as volatility continues without a clear trend. The bull case (25% probability) targets $56 to $60 on a successful turnaround and multiple expansion. The bear case (25% probability) warns of a drop to $30-$35 if losses return and balance sheet concerns escalate. The most likely outcome is the base case, predicated on the assumption that the company's fundamental issues persist but are offset by cheap valuation and buyback support.
EQH appears statistically undervalued based on sales multiples, trading at a trailing PS ratio of 1.22 and an EV/Sales of 0.88, near the bottom of its historical range. However, this 'cheapness' is fully justified by its fundamental problems: negative TTM earnings, a broken balance sheet, and declining revenue. The market is pricing in a high probability of continued distress or failure. Therefore, while the stock is not overvalued, it is fairly valued relative to its substantial risks—it is a value trap unless operations genuinely improve.
EQH is a high-risk, high-potential-reward stock that is not a 'good buy' for most investors. For speculative investors comfortable with severe volatility and fundamental distress, the deeply depressed valuation (PS of 1.22) and unanimous analyst bullishness present a compelling contrarian case. However, the massive Q3 2025 loss, negative shareholder equity, and revenue declines pose existential risks. It could be a good buy only for those who believe the Q4 profit rebound is sustainable and are prepared to lose 15-35% if the bear case materializes.
EQH is not suitable for traditional long-term 'buy-and-hold' investing due to its fundamental instability. It is primarily a speculative, shorter-term tactical trade for investors betting on a specific catalyst: a confirmed operational turnaround over the next 2-4 quarters. Given its high beta (1.13) and lack of a reliable earnings stream or dividend (yield 2.6%), it offers poor visibility for long-term holders. A minimum suggested holding period is 6-12 months, enough time to assess whether the Q4 2025 rebound is sustainable, after which the thesis should be rigorously re-evaluated.